1. Market Research
  2. > Healthcare
  3. > Pathology
  4. > Cancer Market Trends
  5. > Synovial Sarcoma Global Clinical Trials Review, H1, 2015

Synovial Sarcoma Global Clinical Trials Review, H1, 2015

  • February 2015
  • -
  • Global Data
  • -
  • 84 pages

Synovial Sarcoma Global Clinical Trials Review, H1, 2015

Summary

GlobalData's clinical trial report, “Synovial Sarcoma Global Clinical Trials Review, H1, 2015" provides data on the Synovial Sarcoma clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Synovial Sarcoma. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Synovial Sarcoma. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table Of Contents

Synovial Sarcoma Global Clinical Trials Review, H1, 2015
Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Introduction 6
Synovial Sarcoma 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Countries Contributing to Clinical Trials in Middle East and Africa 13
Top Countries Contributing to Clinical Trials in Central and South America 14
Clinical Trials by G7 Countries: Proportion of Synovial Sarcoma to Oncology Clinical Trials 15
Clinical Trials by Phase in G7 Countries 16
Clinical Trials in G7 Countries by Trial Status 17
Clinical Trials by E7 Countries: Proportion of Synovial Sarcoma to Oncology Clinical Trials 18
Clinical Trials by Phase in E7 Countries 19
Clinical Trials by Phase 20
In Progress Trials by Phase 21
Clinical Trials by Trial Status 22
Clinical Trials by End Point Status 23
Unaccomplished Trials of Synovial Sarcoma 24
Subjects Recruited Over a Period of Time 25
Clinical Trials by Sponsor Type 26
Prominent Sponsors 27
Top Companies Participating in Synovial Sarcoma Therapeutics Clinical Trials 28
Prominent Drugs 30
Clinical Trial Profiles 31
Clinical Trial Overview of Top Companies 31
F. Hoffmann-La Roche Ltd. 31
Clinical Trial Overview of F. Hoffmann-La Roche Ltd. 31
Threshold Pharmaceuticals, Inc. 32
Clinical Trial Overview of Threshold Pharmaceuticals, Inc. 32
EpiZyme, Inc. 33
Clinical Trial Overview of EpiZyme, Inc. 33
Eli Lilly and Company 34
Clinical Trial Overview of Eli Lilly and Company 34
Eisai Co., Ltd. 35
Clinical Trial Overview of Eisai Co., Ltd. 35
Daiichi Sankyo Company, Limited 36
Clinical Trial Overview of Daiichi Sankyo Company, Limited 36
Adaptimmune Limited 37
Clinical Trial Overview of Adaptimmune Limited 37
Clinical Trial Overview of Top Institutes / Government 38
National Cancer Institute 38
Clinical Trial Overview of National Cancer Institute 38
European Organization for Research and Treatment of Cancer 39
Clinical Trial Overview of European Organization for Research and Treatment of Cancer 39
Fred Hutchinson Cancer Research Center 40
Clinical Trial Overview of Fred Hutchinson Cancer Research Center 40
University of Heidelberg 41
Clinical Trial Overview of University of Heidelberg 41
Memorial Sloan Kettering Cancer Center 42
Clinical Trial Overview of Memorial Sloan Kettering Cancer Center 42
Massachusetts General Hospital 43
Clinical Trial Overview of Massachusetts General Hospital 43
University Health Network 44
Clinical Trial Overview of University Health Network 44
Children's Oncology Group 45
Clinical Trial Overview of Children's Oncology Group 45
University of Washington 46
Clinical Trial Overview of University of Washington 46
Five Key Clinical Profiles 47
Appendix 81
Abbreviations 81
Definitions 81
Research Methodology 82
Secondary Research 82
About GlobalData 83
Contact Us 83
Disclaimer 83
Source 84

List of Tables
Synovial Sarcoma Therapeutics, Global, Clinical Trials by Region, 2015* 7
Synovial Sarcoma Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 8
Synovial Sarcoma Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 9
Synovial Sarcoma Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2015* 10
Synovial Sarcoma Therapeutics Clinical Trials, Europe, Top Five Countries, 2015* 11
Synovial Sarcoma Therapeutics Clinical Trials, North America, Top Countries, 2015* 12
Synovial Sarcoma Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2015* 13
Synovial Sarcoma Therapeutics Clinical Trials, Central and South America, Top Countries, 2015* 14
Proportion of Synovial Sarcoma to Oncology Clinical Trials, G7 Countries (%), 2015* 15
Synovial Sarcoma Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 16
Synovial Sarcoma Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 17
Proportion of Synovial Sarcoma to Oncology Clinical Trials, E7 Countries (%), 2015* 18
Synovial Sarcoma Therapeutics, E7 Countries, Clinical Trials by Phase, 2015* 19
Synovial Sarcoma Therapeutics, Global, Clinical Trials by Phase, 2015* 20
Synovial Sarcoma Therapeutics, Global, Clinical Trials In Progress by Phase 2015* 21
Synovial Sarcoma Therapeutics, Global, Clinical Trials by Trial Status, 2015* 22
Synovial Sarcoma Therapeutics Clinical Trials, Global, by End Point Status, 2015* 23
Synovial Sarcoma Therapeutics, Global, Terminated Clinical Trials, 2015* 24
Synovial Sarcoma Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 25
Synovial Sarcoma Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2015* 26
Synovial Sarcoma Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 27
Synovial Sarcoma Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 29
Synovial Sarcoma Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 30
Synovial Sarcoma Therapeutics Clinical Trials Market, Global, Clinical Trials by F. Hoffmann-La Roche Ltd., 2015* 31
Synovial Sarcoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Threshold Pharmaceuticals, Inc., 2015* 32
Synovial Sarcoma Therapeutics Clinical Trials Market, Global, Clinical Trials by EpiZyme, Inc., 2015* 33
Synovial Sarcoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Eli Lilly and Company, 2015* 34
Synovial Sarcoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Eisai Co., Ltd., 2015* 35
Synovial Sarcoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Daiichi Sankyo Company, Limited, 2015* 36
Synovial Sarcoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Adaptimmune Limited, 2015* 37
Synovial Sarcoma Therapeutics Clinical Trials Market, Global, Clinical Trials by National Cancer Institute, 2015* 38
Synovial Sarcoma Therapeutics Clinical Trials Market, Global, Clinical Trials by European Organization for Research and Treatment of Cancer, 2015* 39
Synovial Sarcoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Fred Hutchinson Cancer Research Center, 2015* 40
Synovial Sarcoma Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Heidelberg, 2015* 41
Synovial Sarcoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Memorial Sloan Kettering Cancer Center, 2015* 42
Synovial Sarcoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Massachusetts General Hospital, 2015* 43
Synovial Sarcoma Therapeutics Clinical Trials Market, Global, Clinical Trials by University Health Network, 2015* 44
Synovial Sarcoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Children's Oncology Group, 2015* 45
Synovial Sarcoma Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Washington, 2015* 46

List of Figures
Synovial Sarcoma Therapeutics, Global, Clinical Trials by Region (%), 2015* 7
Synovial Sarcoma Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 8
Synovial Sarcoma Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 9
Synovial Sarcoma Therapeutics Clinical Trials, Asia-Pacific, Top Countries (%), 2015* 10
Synovial Sarcoma Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2015* 11
Synovial Sarcoma Therapeutics Clinical Trials, North America, Top Countries (%), 2015* 12
Synovial Sarcoma Therapeutics Clinical Trials, Central and South America, Top Countries (%), 2015* 14
Proportion of Synovial Sarcoma to Oncology Clinical Trials, G7 Countries (%), 2015* 15
Synovial Sarcoma Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 16
Synovial Sarcoma Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 17
Proportion of Synovial Sarcoma to Oncology Clinical Trials, E7 Countries (%), 2015* 18
Synovial Sarcoma Therapeutics, E7 Countries, Clinical Trials by Phase, 2015* 19
Synovial Sarcoma Therapeutics, Global, Clinical Trials by Phase (%), 2015* 20
Synovial Sarcoma Therapeutics, Global, Clinical Trials In Progress by Phase, 2015* 21
Synovial Sarcoma Therapeutics, Global, Clinical Trials by Trial Status, 2015* 22
Synovial Sarcoma Therapeutics Clinical Trials, Global, by End Point Status, 2015* 23
Synovial Sarcoma Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 25
Synovial Sarcoma Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2015* 26
Synovial Sarcoma Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 27
Synovial Sarcoma Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 28
Synovial Sarcoma Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 30
GlobalData Methodology 82

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
Hematological Cancers: Analytical Tool

Hematological Cancers: Analytical Tool

  • $ 11505
  • Industry report
  • August 2016
  • by Bioseeker

Analytical Tools are cancer area specific intelligence and surveillance toolkits within a select number of hot, emerging cancer therapy areas. They are designed to empower biotech/pharma professionals ...

Frontier Pharma: Glioblastoma Multiforme - Cancer Immunotherapies Dominate First-in-Class Product Innovation

Frontier Pharma: Glioblastoma Multiforme - Cancer Immunotherapies Dominate First-in-Class Product Innovation

  • $ 6995
  • Industry report
  • September 2016
  • by GBI Research

Frontier Pharma: Glioblastoma Multiforme - Cancer Immunotherapies Dominate First-in-Class Product Innovation Summary Glioblastoma multiforme (GBM) is a grade IV tumor that arises from astrocytes. It is ...

Lung Cancer: Analytical Tool

Lung Cancer: Analytical Tool

  • $ 8096
  • Industry report
  • August 2016
  • by Bioseeker

Analytical Tools are cancer area specific intelligence and surveillance toolkits within a select number of hot, emerging cancer therapy areas. They are designed to empower biotech/pharma professionals ...

Ovarian Cancer: Analytical Tool

August 2016 $ 8096

Renal Cancer: Analytical Tool

August 2016 $ 8096

Bladder Cancer: Analytical Tool

August 2016 $ 8096

Brain Cancer: Analytical Tool

August 2016 $ 8096

Breast Cancer: Analytical Tool

August 2016 $ 8096

ref:plp2015

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.